Berkeley Capital Partners, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,133 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.

Quarter-by-quarter ownership
Berkeley Capital Partners, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2024$1,937,998
+10.4%
18,204
+0.3%
0.58%
+9.2%
Q1 2024$1,755,843
+177.8%
18,152
+190.0%
0.54%
+156.0%
Q4 2023$631,972
-3.6%
6,259
-2.8%
0.21%
-11.8%
Q3 2023$655,673
-3.0%
6,437
-3.9%
0.24%
-0.8%
Q2 2023$675,694
-55.6%
6,696
-59.5%
0.24%
-57.6%
Q1 2023$1,522,876
+2.8%
16,553
+1.4%
0.56%
-1.6%
Q4 2022$1,480,732
+24.7%
16,322
+4.5%
0.57%
+11.5%
Q3 2022$1,187,000
-0.3%
15,622
+10.9%
0.51%
+4.7%
Q2 2022$1,191,000
+8.1%
14,087
+12.2%
0.49%
+11.8%
Q1 2022$1,102,000
+228.0%
12,557
+226.7%
0.44%
+218.1%
Q4 2021$336,000
+43.6%
3,844
+34.3%
0.14%
+27.8%
Q3 2021$234,000
-8.2%
2,863
+2.3%
0.11%
-5.3%
Q2 2021$255,000
+0.4%
2,798
-5.7%
0.11%
-7.3%
Q1 2021$254,000
-4.9%
2,966
+5.1%
0.12%
-10.2%
Q4 2020$267,000
+9.9%
2,823
+0.9%
0.14%
-7.4%
Q3 2020$243,000
-4.7%
2,798
-4.3%
0.15%
-5.7%
Q2 2020$255,000
+2.0%
2,924
-3.4%
0.16%
-7.6%
Q1 2020$250,000
-19.4%
3,027
-7.6%
0.17%
+6.9%
Q4 2019$310,000
+8.0%
3,277
-0.8%
0.16%
+5.3%
Q3 2019$287,000
-8.3%
3,304
-3.6%
0.15%
+3.4%
Q2 2019$313,000
-5.7%
3,428
-0.7%
0.15%
-11.0%
Q1 2019$332,000
+15.7%
3,453
+3.1%
0.16%
+2.5%
Q4 2018$287,000
+1.4%
3,348
+1.8%
0.16%
+0.6%
Q3 2018$283,000
+23.6%
3,288
+23.4%
0.16%
+3.9%
Q3 2017$229,000
-58.2%
2,665
-59.4%
0.15%
-59.0%
Q2 2017$548,0006,5650.37%
Other shareholders
NOVARTIS A G shareholders Q2 2020
NameSharesValueWeighting ↓
Martin Investment Management, LLC 318,637$27,960,0007.08%
MANAGED ASSET PORTFOLIOS, LLC 417,183$36,608,0005.02%
SAL Trading, LLC 233,600$20,498,0004.77%
SCHARF INVESTMENTS, LLC 1,340,680$117,662,0003.49%
SAL Trading, LLC 155,783$13,670,0003.18%
First Fiduciary Investment Counsel, Inc. 169,371$14,862,0002.90%
PRENTISS SMITH & CO INC 55,026$4,829,0002.90%
GARLAND CAPITAL MANAGEMENT INC 47,630$4,180,0002.77%
Cullen Capital Management, LLC 3,295,271$289,160,0002.66%
WILKINS INVESTMENT COUNSEL INC 133,880$11,748,0002.65%
View complete list of NOVARTIS A G shareholders